Oncologists Accepting Humana in Boston, MA
93 verified oncologists in Boston, Massachusetts accept Humana. Profiles cover focus areas including Genitourinary Oncology, Medical Oncology, and Head & Neck Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Massachusetts General Hospital.


Ursula Matulonis, MD
Professor of Medicine, Harvard Medical School; Chief and Director, Division of Gynecologic Oncology, Dana-Farber Cancer Institute
Oncology


Robert Haddad, MD
Chief, Division of Head and Neck Oncology; McGraw Chair in Head and Neck Oncology; Professor of Medicine, Harvard Medical School
Oncology


Patrick Ott, MD
Professor of Medicine, Harvard Medical School; Clinical Director, Melanoma Disease Center; Director, Clinical Sciences, Center for Immuno-Oncology; Senior Physician
Oncology


Kenneth Anderson, MD
Kraft Family Professor of Medicine, Harvard Medical School; Director, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute
Oncology


Vincent Ho, MD
Professor of Medicine, Harvard Medical School; Director of Clinical Operations, Stem Cell Transplantation, Dana-Farber Cancer Institute
Oncology


Susana Campos, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School
Oncology


Suzanne George, MD
Chief, Division of Sarcoma; Clinical Research Director, Sarcoma Center; Associate Professor of Medicine, Harvard Medical School
Oncology


Joseph Antin, MD
Chairman of the Steering Committee of the BMT Clinical Trial Network.; Chief, Stem Cell Transplantation, Emeritus
Oncology


Jennifer Chan, MD
Associate Professor of Medicine, Harvard Medical School; Clinical Director, Gastrointestinal Cancer Center; Director, Program in Carcinoid and Neuroendocrine Tumors, Dana-Farber Cancer Institute
Oncology


Robert Soiffer, MD
Chief of the Division of Hematologic Malignancies; Codirector of the Adult Stem Cell Transplantation Program; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School
Oncology


Harold Burstein, MD PHD
Director of Academic Partnerships; Director of Breast Cancer Education
Oncology


Howard Kaufman, M.D.
Professor, Surgery
Oncology


Arnold Freedman, MD
Professor of Medicine at Harvard Medical School, a member of Dana-Farber Cancer Institute's Department of Medical Oncology, and an attending physician at Brigh; Professor of Medicine, Harvard Medical School
Oncology


Erica Mayer, MD MPH
Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School; Director, Breast Cancer Clinical Research, Dana-Farber Breast Oncology Program
Oncology


Jennifer Ligibel, MD
Professor at Harvard Medical School and a Senior Physician in the Breast Oncology Center at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on; Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living and has built a comprehensive clinical Healthy Living Program for patient
Oncology


Bruce Johnson, MD
Professor Emeritus of Medicine, Harvard Medical School; Institute Physician, Dana-Farber Cancer Institute
Oncology


Ann Partridge, MD MPH
Chief Clinical Strategy Officer, Vice Chair of Medical Oncology, and founder and director of Young and Strong, the Program for Young Adults with Breast Can; Chair in Breast Cancer Research at Dana-Farber. She conducts clinical research focused on improving cancer care and outcomes with a particular focus on you
Oncology


Elizabeth Buchbinder, M.D.
Assistant Professor of Medicine, Harvard Medical School
Oncology


Jiping Wang, MD, PHD
Surgical Oncologist, Associate Professor of Surgery, Harvard Medical School
Oncology


Filipa Lynce, M.D.
Assistant Professor of Medicine, Harvard Medical School; Associate Director, Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute
Oncology